ZERBATO, BARBARA
 Distribuzione geografica
Continente #
AS - Asia 1.414
NA - Nord America 1.119
EU - Europa 895
SA - Sud America 233
AF - Africa 53
OC - Oceania 10
Totale 3.724
Nazione #
US - Stati Uniti d'America 1.064
SG - Singapore 503
IT - Italia 438
CN - Cina 364
BR - Brasile 170
VN - Vietnam 152
HK - Hong Kong 107
RU - Federazione Russa 88
DE - Germania 70
FR - Francia 59
IN - India 57
GB - Regno Unito 45
KR - Corea 43
FI - Finlandia 31
PL - Polonia 28
ID - Indonesia 27
JP - Giappone 27
CA - Canada 26
TR - Turchia 26
AR - Argentina 25
ZA - Sudafrica 25
NL - Olanda 24
MX - Messico 19
ES - Italia 18
BD - Bangladesh 17
CH - Svizzera 16
IE - Irlanda 15
IQ - Iraq 14
SE - Svezia 14
CO - Colombia 11
PH - Filippine 11
UZ - Uzbekistan 8
AT - Austria 7
CL - Cile 7
MA - Marocco 7
SA - Arabia Saudita 7
TW - Taiwan 7
AU - Australia 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
IR - Iran 6
JO - Giordania 5
PK - Pakistan 5
PT - Portogallo 5
PY - Paraguay 5
TN - Tunisia 5
VE - Venezuela 5
DK - Danimarca 4
DZ - Algeria 4
GR - Grecia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
UA - Ucraina 4
AL - Albania 3
AZ - Azerbaigian 3
JM - Giamaica 3
KE - Kenya 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EG - Egitto 2
HU - Ungheria 2
KZ - Kazakistan 2
LT - Lituania 2
NO - Norvegia 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
NI - Nicaragua 1
PA - Panama 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 3.724
Città #
Singapore 265
Milan 170
San Jose 163
Ashburn 155
Hong Kong 94
Hefei 76
Dallas 71
Beijing 64
Ho Chi Minh City 54
Los Angeles 53
New York 46
Seoul 40
Chicago 38
Hanoi 38
Buffalo 36
Santa Clara 32
Frankfurt am Main 28
Lauterbourg 27
Jakarta 21
Johannesburg 20
The Dalles 20
Warsaw 20
Atlanta 19
Ann Arbor 17
São Paulo 17
Turin 17
Tokyo 16
Denver 15
Houston 15
Montreal 15
Dublin 14
Rome 14
Boardman 13
Chennai 13
Munich 13
Orem 13
Bologna 12
Council Bluffs 12
Guangzhou 11
Helsinki 11
Hyderabad 11
Nuremberg 11
Moscow 10
Baghdad 9
Zurich 9
Ankara 8
Lodi 8
Monza 8
Naples 8
Rio de Janeiro 8
Seattle 8
Da Nang 7
Manchester 7
Tampere 7
Turate 7
Brooklyn 6
Buenos Aires 6
Chandler 6
City of London 6
Florence 6
London 6
Mumbai 6
Phoenix 6
Querétaro 6
San Francisco 6
Shanghai 6
Stockholm 6
Tashkent 6
Turku 6
Amman 5
Amsterdam 5
Brescia 5
Bussero 5
Como 5
Desio 5
Dhaka 5
Groningen 5
Istanbul 5
Paris 5
Santo Tirso 5
Seveso 5
Taranto 5
Triei 5
Verona 5
Boston 4
Brugherio 4
Bắc Ninh 4
Copenhagen 4
Manila 4
Mexico City 4
Poplar 4
Santiago 4
Saronida 4
Sydney 4
Toronto 4
Walnut Creek 4
Wroclaw 4
Barnet 3
Bexley 3
Bogotá 3
Totale 2.134
Nome #
The Association between Vitamin D and Gut Microbiota: A Systematic Review of Human Studies 280
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 271
PGM3 inhibition Shows cooperative Effects With Erastin inducing Pancreatic cancer cell death via activation of the Unfolded Protein Response 257
Chiral trimethyl lock based on vicinal disubstituent effect: prolonged release of Camptothecin into cancer cells 256
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis 223
PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response 214
Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy 200
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 191
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 185
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 171
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 154
Inhibition of the Hexosamine Biosynthetic Pathway Enhances Enzalutamide Response in Prostate Cancer Cells 138
Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage 131
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 124
Targeting the Hexosamine Biosynthetic Pathway with a novel PGM3 inhibitor, FR054, to suppress tumour growth and enhance chemotherapy sensitivity in cancer 120
Hexosamine Biosynthetic Pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 111
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 91
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 86
Exploiting DNA damage response protein O-glycosylation to enhance chemotherapy in pancreatic cancer. 84
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 84
Exploiting DNA damage protein O-glycosylation to enhance chemotherapy in pancreatic cancer 83
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 75
Inhibition of HBP by targeting PGM3 enzyme as new anticancer therapy 75
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 72
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 71
Hexosamine biosynthetic pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 68
null 3
Totale 3.818
Categoria #
all - tutte 9.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 0 0 0 9 11 8 7 5 1 2 1 1
2022/202385 5 6 3 16 8 10 1 7 9 0 15 5
2023/2024125 6 2 5 18 9 12 13 7 11 1 10 31
2024/2025763 28 79 83 33 55 30 76 22 58 106 84 109
2025/20262.800 159 126 395 391 418 216 380 113 280 289 33 0
Totale 3.818